Information for Healthcare Professionals: Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)*
|Update: The information described in this communication have been addressed in product labeling (see Drugs@FDA).|
Physicians are encouraged to carefully weigh the potential benefits and risks of NSAIDs and other treatment options for the condition to be treated before a decision is made to use an NSAID. If chronic use of an NSAID is selected for an individual patient, the lowest effective dose for the shortest duration consistent with individual patient treatment goals should be used.
NSAIDs should not be used in patients who are immediately post-operative from CABG surgery.
- Extensive data on the cardiovascular safety of NSAIDs were presented at the Joint Meeting on February 16, 17, and 18, 2005, of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee. This information is available on the following website: Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee Joint Meeting
*A list of prescription NSAIDS is available on the Internet.
Adverse reactions or quality problems experienced with the use of this Product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax, using the contact information at the bottom of this sheet.